Intravacc announces positive data of first in human
First in human phase I clinical study using OMV as an adjuvant for intranasal vaccinationAvacc 10® intranasal booster vaccine induces ...
Read moreFirst in human phase I clinical study using OMV as an adjuvant for intranasal vaccinationAvacc 10® intranasal booster vaccine induces ...
Read moreThree additional patients with Fanconi Anemia treated with briquilimab prior to stem cell transplantAll six patients with Fanconi Anemia treated ...
Read moreMIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company ...
Read moreReliaable Developers, a leading force in Bangalore's plotted development sector, unveils a striking new logo as a cornerstone of ...
Read more– STRIDE Phase 2 primary endpoint of PASI 75 and key secondary endpoints met at all clinically relevant doses tested; ...
Read more- Primary and secondary endpoints met with clinically meaningful and statistically significant decreases in urticaria disease activity across multiple dose ...
Read moreBexotegrast (PLN-74809) at 320 mg was well tolerated over 12 weeks of treatment with no drug-related severe or serious adverse events; ...
Read more51 wet AMD patients with severe disease activity (mean of 442 µm central subfield thickness & presence of retinal fluid) ...
Read moreFrankfurt am Main/ New Delhi, 1 February 2024. Due to the great demand, the organisers are opening up additional halls ...
Read moreFrankfurt am Main/ New Delhi, 1 February 2024. Due to the great demand, the organisers are opening up additional halls ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.